Niels Vander Elst

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Venues

Applied microbiology and biotechnology

Acta veterinaria Scandinavica

Veterinary research

Antibiotics (Basel, Switzerland)

Ghent University

Ghent University (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ghent University

Belgium

PhD Researcher :: Department of Pharmacology, Toxicology and Biochemistry

Education History

Ghent University

Belgium

MSC

Publications

Niels Vander Elst, Julie Bellemans, Rob Lavigne, Yves Briers, Evelyne Meyer
Endolysin NC5 improves early cloxacillin treatment in a mouse model of Streptococcus uberis mastitis. Applied microbiology and biotechnology 108 (1) (2024)
Niels Vander Elst
Bacteriophage-derived endolysins as innovative antimicrobials against bovine mastitis-causing streptococci and staphylococci: a state-of-the-art review. Acta veterinaria Scandinavica 66 (1) (2024)
Niels Vander Elst, Julie Bellemans, Rob Lavigne, Yves Briers, Evelyne Meyer
Endolysin NC5 improves early cloxacillin treatment in a mouse model of Streptococcus uberis mastitis. Applied microbiology and biotechnology 108 (1) (2024)
Niels Vander Elst
Bacteriophage-derived endolysins as innovative antimicrobials against bovine mastitis-causing streptococci and staphylococci: a state-of-the-art review. Acta veterinaria Scandinavica 66 (1) (2024)
Niels Vander Elst, Julie Bellemans, Rob Lavigne, Yves Briers, Evelyne Meyer
Endolysin NC5 improves early cloxacillin treatment in a mouse model of Streptococcus uberis mastitis. Applied microbiology and biotechnology 108 (1) (2024)
Niels Vander Elst, Julie Bellemans, Rob Lavigne, Yves Briers, Evelyne Meyer
Endolysin NC5 improves early cloxacillin treatment in a mouse model of Streptococcus uberis mastitis. Applied microbiology and biotechnology 108 (1) (2024)
Niels Vander Elst
Bacteriophage-derived endolysins as innovative antimicrobials against bovine mastitis-causing streptococci and staphylococci: a state-of-the-art review. Acta veterinaria Scandinavica 66 (1) (2024)
Niels Vander Elst
Bacteriophage-derived endolysins as innovative antimicrobials against bovine mastitis-causing streptococci and staphylococci: a state-of-the-art review. Acta veterinaria Scandinavica 66 (1) (2024)
Niels Vander Elst, Julie Bellemans, Rob Lavigne, Yves Briers, Evelyne Meyer
Endolysin NC5 improves early cloxacillin treatment in a mouse model of Streptococcus uberis mastitis. Applied microbiology and biotechnology 108 (1) (2024)
Niels Vander Elst, Julie Bellemans, Rob Lavigne, Yves Briers, Evelyne Meyer
Endolysin NC5 improves early cloxacillin treatment in a mouse model of Streptococcus uberis mastitis. Applied microbiology and biotechnology 108 (1) (2024)
Niels Vander Elst, Julie Bellemans, Jonas Steenbrugge, Chloë Geeroms, Koen Breyne, Sofie Piepers, Bruno Toledo-Silva, Fernando Nogueira de Souza, Freddy Haesebrouck, Sarne De Vliegher, Evelyne Meyer
Priming of the murine mammary gland with Staphylococcus chromogenes IM reduces bacterial growth of Streptococcus uberis: a proof-of-concept study. Veterinary research 54 (1) (2023)
Niels Vander Elst, Julie Bellemans, Jonas Steenbrugge, Chloë Geeroms, Koen Breyne, Sofie Piepers, Bruno Toledo-Silva, Fernando Nogueira de Souza, Freddy Haesebrouck, Sarne De Vliegher, Evelyne Meyer
Priming of the murine mammary gland with Staphylococcus chromogenes IM reduces bacterial growth of Streptococcus uberis: a proof-of-concept study. Veterinary research 54 (1) (2023)
Niels Vander Elst, Julie Bellemans, Jonas Steenbrugge, Chloë Geeroms, Koen Breyne, Sofie Piepers, Bruno Toledo-Silva, Fernando Nogueira de Souza, Freddy Haesebrouck, Sarne De Vliegher, Evelyne Meyer
Priming of the murine mammary gland with Staphylococcus chromogenes IM reduces bacterial growth of Streptococcus uberis: a proof-of-concept study. Veterinary research 54 (1) (2023)
Niels Vander Elst, Joni Bert, Herman W Favoreel, Rob Lavigne, Evelyne Meyer, Yves Briers
Development of engineered endolysins with in vitro intracellular activity against streptococcal bovine mastitis-causing pathogens. Microbial biotechnology (2023)
Jonas Steenbrugge, Niels Vander Elst, Kristel Demeyere, Olivier De Wever, Niek N Sanders, Wim Van Den Broeck, Eric Ciamporcero, Timothy Perera, Evelyne Meyer
OMO-1 reduces progression and enhances cisplatin efficacy in a 4T1-based non-c-MET addicted intraductal mouse model for triple-negative breast cancer. NPJ breast cancer 7 (1) (2021)
Niels Vander Elst, Sara B Linden, Rob Lavigne, Evelyne Meyer, Yves Briers, Daniel C Nelson
Characterization of the Bacteriophage-Derived Endolysins PlySs2 and PlySs9 with In Vitro Lytic Activity against Bovine Mastitis Streptococcus uberis. Antibiotics (Basel, Switzerland) 9 (9) (2020)

Niels Vander Elst.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Niels Vander Elst